Erwin Troxler

HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments.

Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.

Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland.

AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany.

Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Tensys Medical, Inc. develops blood pressure monitoring systems. The firm provides patient safety by designing, and manufacturing continuous, non-invasive hemodynamic monitoring systems. The company was founded in 1995 and is headquartered in San Diego, CA.

Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ.

Wellington Partners GmbH (Wellington Partners) is a venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, Germany.

CardiacAssist, Inc. develops, manufactures and markets medical devices. The firm’s products include TandemLife Kit, TandemHeart Kit, TandemLung Kit, ProtekDuo Kit and educational videos. The company was founded by John C. Marous, Jr. and George J. Magovern in 1996 and is headquartered in Pittsburgh, PA.

i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands.

Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA.

Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland.

BioMedPartners AG (BioMedPartners) is an independent venture capital firm founded in 2002. The firm is headquartered in Basel, Switzerland.

Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.

Founded in 1966, FRORIEP Legal AG is a law firm that was acquired by MLL Meyerlustenberger Lachenal Froriep AG on June 30, 2021. Part of MLL Meyerlustenberger Lachenal Froriep AG, the company is based in Zurich, Switzerland. The law firms Meyerlustenberger Lachenal and FRORIEP Legal announced the successful closing of their merger as intimated in December 2020. From 1 July 2021, MLL.

Crypto Finance AG operates as a financial technology holding company. It provides blockchain-related services through its subsidiaries: Crypto Fund AG (Asset Management), Crypto Broker AG (Brokerage), and Crypto Storage AG (Storage). The company was founded by Jan Brzezek and Tobias Reichmuth in June 2017 and is headquartered in Zug, Switzerland.

Müller-Steinag Element AG is a private company based in Rickenbach, Switzerland. The Swiss company specializes in providing a diverse range of aesthetic and beautiful outdoor furniture, embankments, garden equipment, walls, natural building materials, and paths. The company is committed to building the world with the best quality concrete and customized developments for every requirement. The company's product range includes outdoor furniture, embankments, garden equipment, walls, natural building materials, and paths.

MLL Meyerlustenberger Lachenal Froriep AG is a leading law firm in Switzerland that provides legal advice to companies from all over the world. The private company was founded in 1882 and is based in Zurich, Switzerland, with subsidiaries in Switzerland, including offices in Geneva, Zug, and others. The firm utilizes Legal Tech as collaboration and communication tools, as well as in their service offerings. MLL Legal has expertise in various areas such as industry groups, country desks, and special desks.

Meyer Burger AG operates as a holding company, which engages in the provision of product equipment and services for the manufacture of solar wafers, cells, and modules. The firm serves to the solar, semiconductor, and optoelectronic industries and other sectors related to semiconductor materials. The company was founded in 1953 and is headquartered in Thun, Switzerland.

Part of SO Holding AG, Horizon21 AG is a Swiss company that provides private equity services. The company is based in Pfäffikon, Switzerland. The company was founded by Rainer-Marc Frey, Adrian Gut.